Trial Profile
A Phase I Study of S-1 With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Apr 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions
- 05 Mar 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 05 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.